Amanote Research
Register
Sign In
Gilteritinib Likely New Standard Care for AML
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2019-046
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 1, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Preconception Care: A New Standard of Care Within Maternal Health Services
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Teleconsultation for Left Ventricular Assist Device Patients: A New Standard of Care
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Endovascular Mechanical Thrombectomy for Acute Ischemic Stroke: A New Standard of Care
Journal of Stroke
Neurology
Cardiovascular Medicine
Cardiology
Targeting mTOR for the Treatment of AML. New Agents and New Directions.
Oncotarget
Oncology
Data Offers New Insights Into AML
Cancer Discovery
Oncology
Standard of Care
Journal of Empirical Research on Human Research Ethics
Medicine
Communication
Law
Education
Social Psychology
New Standard for Localized UTUC
Nature Reviews Urology
Urology
Standard of Care
Medico-Legal Journal
Medicine
Thalidomide and Dexamethasone: A New Standard of Care for Initial Therapy in Multiple Myeloma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology